[{"ID":"12720_27_NCT03296930","TOPIC_YEAR":2021,"RESPONSE":"$}}%\n\nB","PROBA":0.9999875665},{"ID":"30672_65_NCT01883024","TOPIC_YEAR":2021,"RESPONSE":"$}}%> A: eligible  B: excluded  C: not relevant for clinical trial","PROBA":0.9781402864},{"ID":"12418_27_NCT00720434","TOPIC_YEAR":2021,"RESPONSE":"$}}%\n\nB: excluded","PROBA":0.9999956936},{"ID":"17032_36_NCT01491828","TOPIC_YEAR":2021,"RESPONSE":"$}}%E2%80%8B%20A%3A%20eligible%20B%3A%20excluded%20C%3A%20not%20relevant%20for%20clinical%20trial.","PROBA":0.9878395093},{"ID":"7100_15_NCT04821219","TOPIC_YEAR":2021,"RESPONSE":"$}}%\n\nBased on the patient's history of pancreatic adenocarcinoma and the inclusion criteria of the clinical trial, the patient is eligible for the study. The patient has undergone EUS with biopsy, which has confirmed the diagnosis of pancreatic adenocarcinoma at the head of the pancreas. This meets the inclusion criterion of a confirmed diagnosis of pancreatic adenocarcinoma. Additionally, the patient's history of coronary artery disease, mitral valve prolapse, atrial fibrillation, hyperlipemia, hypertension, chronic kidney disease, hypothyroidism, and anemia do not meet any of the exclusion criteria listed in the clinical trial. Therefore, the patient is eligible for the study.\n\nAnswer: A","PROBA":0.9954514007},{"ID":"8090_17_NCT04210791","TOPIC_YEAR":2021,"RESPONSE":"$}}%\n\nB: excluded","PROBA":0.9999993443},{"ID":"7091_15_NCT04730765","TOPIC_YEAR":2021,"RESPONSE":"# A: eligible\n# B: excluded\n# C: not relevant for clinical trial","PROBA":0.9999882181},{"ID":"10176_15_NCT02081625","TOPIC_YEAR":2022,"RESPONSE":"$}}%\n\nB: excluded. The patient is excluded from the clinical trial because they have participated in other pharmacological clinical trial that might recover dystrophin protein by the readthrough or the exon-skipping therapy.","PROBA":0.9831793099},{"ID":"12547_27_NCT01750515","TOPIC_YEAR":2021,"RESPONSE":"$}}%\n\nBased on the information provided, the patient is eligible for the clinical trial. The patient meets all the inclusion criteria, such as having chronic HCV infection, being over 18 years old, and being able to receive standard Peg interferon+ribavirin treatment. The patient does not have any of the exclusion criteria, such as psychiatric diagnosis, anemia of hematologic origin, diabetic patient with uncontrolled diabetes, congestive heart failure or arrhythmia, hepatocellular carcinoma, HIV infection, hepatitis B infection, or autoimmune liver disease or alcoholic liver disease. Therefore, the patient is eligible for the clinical trial. The correct answer is A: eligible.","PROBA":0.9964256846},{"ID":"8073_17_NCT03984721","TOPIC_YEAR":2021,"RESPONSE":"$}}%\n\nB: excluded. The patient has systemic amyloidosis, which is an inclusion criterion, but the clinical trial specifically excludes patients with systemic amyloidosis.","PROBA":0.9688095924},{"ID":"12485_27_NCT01292161","TOPIC_YEAR":2021,"RESPONSE":"$}}%>\n\nB: excluded","PROBA":0.9229533308},{"ID":"7792_17_NCT00961467","TOPIC_YEAR":2021,"RESPONSE":"$}}%>\n\nB: excluded","PROBA":0.9793190493},{"ID":"25398_36_NCT03086018","TOPIC_YEAR":2022,"RESPONSE":"$}}%E2%80%8B%20B%3A%20excluded%20-%20active%20ear%20disease%20\n\nBased on the patient's history of sensorineural hearing loss in the left ear, the patient is excluded from the clinical trial due to active ear disease.","PROBA":0.9729683188},{"ID":"7690_17_NCT00153933","TOPIC_YEAR":2021,"RESPONSE":"$}}%\n\nB: excluded. The patient has renal insufficiency (serum creatinine levels > 2mg\/dL) which is one of the exclusion criteria for the clinical trial.","PROBA":0.9910287758},{"ID":"14123_30_NCT02758977","TOPIC_YEAR":2021,"RESPONSE":"# A: eligible","PROBA":0.999871932},{"ID":"11608_17_NCT01695369","TOPIC_YEAR":2022,"RESPONSE":"$}}%\n\nB: excluded","PROBA":0.9286536686},{"ID":"30849_65_NCT03362762","TOPIC_YEAR":2021,"RESPONSE":"$}}%\n\nB: excluded","PROBA":0.9899530336},{"ID":"5559_12_NCT04731493","TOPIC_YEAR":2021,"RESPONSE":"$}}%\n\nA: eligible","PROBA":0.989790327},{"ID":"30801_65_NCT02782195","TOPIC_YEAR":2021,"RESPONSE":"$}}%E2%80%8B%20B:%20excluded%20-%20The%20patient%20has%20cardiomyopathy%2C%20which%20is%20an%20exclusion%20criterion%20for%20the%20study.%20Additionally%2C%20the%20patient%27s%20age%20(25)%20is%20outside%20the%20study%27s%20age%20range%20(16-24).)%20C:not%20relevant%20for%20clinical%20trial","PROBA":0.9970420612},{"ID":"6986_15_NCT03858192","TOPIC_YEAR":2021,"RESPONSE":"$}}%\n\nB: excluded","PROBA":0.9803684056},{"ID":"7703_17_NCT00256776","TOPIC_YEAR":2021,"RESPONSE":"$}}%\n\nB: excluded","PROBA":0.9996436834},{"ID":"19031_27_NCT04148222","TOPIC_YEAR":2022,"RESPONSE":"$}}%\n\nBased on the information provided, the patient is eligible for the clinical trial. The patient has been diagnosed with Lyme disease, which is the focus of the clinical trial. None of the exclusion criteria listed in the clinical trial are met, as the patient has not had bariatric surgery, total colectomy, proctocolectomy, or participation in any experimental drug protocol within the past 12 weeks. Additionally, the patient does not have any clinically significant evidence of disease that could interfere with their ability to participate in the trial, and they are able to adequately communicate with the investigator and comply with the requirements of the study. Therefore, the answer is (A) eligible.","PROBA":0.9888913704},{"ID":"7701_17_NCT00240162","TOPIC_YEAR":2021,"RESPONSE":"$}}%E2%80%8B%20B%3A%20excluded%20-%20the%20patient%20has%20amyloidosis%2C%20which%20is%20exclusion%20criterion%20%234.","PROBA":0.9890946929},{"ID":"25463_36_NCT03600324","TOPIC_YEAR":2022,"RESPONSE":"$}}%\n\nB: excluded. The patient does not meet the inclusion criteria because she has a history of hypothyroidism and low vitamin D level, which are excluded criteria for the clinical trial. Additionally, the patient's dizziness symptoms may be related to her hypothyroidism and low vitamin D level, which would make her ineligible for the trial.","PROBA":0.9783280832},{"ID":"14162_30_NCT03296878","TOPIC_YEAR":2021,"RESPONSE":"$}}%\n\nBased on the information provided, the patient is not eligible for the clinical trial because she is not a mother, and children do not live with her in her household. The exclusion criteria state that the subject must be a mother, or children must be living with the subject in their household, which the patient does not meet. Therefore, the answer is B: excluded.","PROBA":0.9888574775},{"ID":"6964_15_NCT03578445","TOPIC_YEAR":2021,"RESPONSE":"$}}%>","PROBA":0.8809370597},{"ID":"10316_15_NCT03433807","TOPIC_YEAR":2022,"RESPONSE":"$}}%\n\nBased on the patient note, the patient is eligible for the clinical trial. The patient has been diagnosed with Duchenne Muscular Dystrophy (DMD) and the clinical trial is specifically for participants with DMD. None of the exclusion criteria are met, as the patient is not at high-risk of a fatal outcome from lung infection and\/or advanced cardiomyopathy, does not have known moderate or severe impairment of hepatic function or severe impairment of renal function, and does not have a prior or ongoing medical condition or laboratory abnormality that would interfere with the patient's participation in the program. Therefore, the patient is eligible for the clinical trial. The correct answer is A: eligible.","PROBA":0.9947627776},{"ID":"16862_36_NCT00105066","TOPIC_YEAR":2021,"RESPONSE":"$}}%\n\nBased on the information provided, the patient is excluded from the clinical trial because she has a BMI of 41.54, which is above the exclusion criterion of BMI >35. Additionally, she has a history of PCO, which is not listed as an exclusion criterion but may be relevant to the study. Therefore, the answer is B: excluded.","PROBA":0.9807951505},{"ID":"27576_40_NCT00970658","TOPIC_YEAR":2022,"RESPONSE":"$}}%>","PROBA":0.8353342811},{"ID":"10221_15_NCT02398786","TOPIC_YEAR":2022,"RESPONSE":"$}}%\n\nBased on the information provided, the patient is eligible for the clinical trial because they have been diagnosed with DMD, which meets the inclusion criteria of the trial. The exclusion criteria of \"not diagnosed with DM, unaffected family members\" do not apply to the patient, as they have been diagnosed with DMD. Therefore, the answer is A: eligible.","PROBA":0.9870250396},{"ID":"12509_27_NCT01498068","TOPIC_YEAR":2021,"RESPONSE":"$}}%E2%80%8B%20B%3A%20excluded%20-%20The%20patient%20has%20prior%20non-responder%20status%20and%20is%20therefore%20excluded%20from%20the%20study.%20The%20patient%E2%80%99s%20history%20of%20inguinal%20hernia%20surgery%20is%20not%20a%20reason%20for%20exclusion.%20The%20patient%E2%80%99s%20absence%20of%20alcoholic%20liver%20disease%2C%20bleeding%20from%20esophageal%20varices%2C%20hemochromatosis%2C%20autoimmune%20hepatitis%20or%20metabolic%20liver%20disease%20is%20not%20a%20reason%20for%20exclusion.%20The%20patient%E2%80%99s%20BMI%20of%2027%20is%20not%20a%20reason%20for%20exclusion.%20The%20patient%E2%80%99s%20absence%20of%20evidence%20of%20hepatocellular%20carcinoma%20is%20not%20a%20reason%20for%20exclusion.%20The%20patient%E2%80%99s%20recent%20biopsy%20was%20negative%20for%20hepatocellular%20carcinoma%2C%20which%20is%20not%20a%20reason%20for%20exclusion.%20The%20patient%E2%80%99s%20absence%20of%20evidence%20of%20alcoholic%20liver%20disease%2C%20bleeding%20from%20esophageal%20varices%2C%20hemochromatosis%2C%20autoimmune%20hepatitis%20or%20metabolic%20liver%20disease%20is%20not%20a%20reason%20for%20exclusion.%20The%20patient%E2%80%99s%20absence%20of%20evidence%20of%20hepatocellular%20carcinoma%20is%20not%20a%20reason%20for%20exclusion.%20The%20patient%E2%80%99s%20recent%20biopsy%20was%20negative%20for%20hepatocellular%20carcinoma%2C%20which%20is%20not%20a%20reason%20for%20exclusion.%20The%20patient%E2%80%99s%20absence%20of%20evidence%20of%20alcoholic%20liver%20disease%2C%20bleeding%20from%20esophageal%20varices%2C%20hemochromatosis%2C%20autoimmune%20hepatitis%20or%20metabolic%20liver%20disease%20is%20not%20a%20reason%20for%20exclusion.%20The%20patient%E2%80%99s%20absence%20of%20evidence%20","PROBA":0.9990486307},{"ID":"21420_30_NCT04397484","TOPIC_YEAR":2022,"RESPONSE":"$}}%>","PROBA":0.8954997261},{"ID":"12359_27_NCT00164073","TOPIC_YEAR":2021,"RESPONSE":"$}}%>\n\nBased on the information provided in the patient note, the patient is eligible for the clinical trial. The patient has a chronic HCV infection, which is the primary inclusion criterion for the trial. Additionally, the patient is not excluded by any of the exclusion criteria listed, such as infection with HIV or HBV, excess ethanol consumption, or other diseases of the liver. Therefore, the answer is B: eligible.","PROBA":0.9865843018},{"ID":"7078_15_NCT04604730","TOPIC_YEAR":2021,"RESPONSE":"$}}%\n\nBased on the patient's note, the patient is excluded from the clinical trial because the patient has a history of perforated diverticulitis, which is not included in the inclusion criteria. The inclusion criteria specify \"generalized peritonitis due to perforated diverticulitis,\" which does not match the patient's condition. Therefore, option B (excluded) is the correct answer.","PROBA":0.9971661902},{"ID":"17158_36_NCT02556749","TOPIC_YEAR":2021,"RESPONSE":"$}}%\n\nBased on the patient note, the patient is not eligible for the clinical trial. The patient has a BMI of 41.54, which falls under the exclusion criterion of \"stage II hypertension (blood pressure \u2265 160\/100 mmHg).\" Additionally, the patient has a history of sleep apnea, which is not listed as an exclusion criterion but may be a concern for the study as it could affect the patient's ability to participate in the study. Therefore, the patient is not eligible for the clinical trial. The correct answer is (B) excluded.","PROBA":0.9892533542},{"ID":"25316_36_NCT02467244","TOPIC_YEAR":2022,"RESPONSE":"$}}%\n\nBased on the patient's note, the patient is eligible for the clinical trial. The patient has hypothyroidism, which is the primary inclusion criterion for the study. Additionally, the patient is not taking any other medications and does not have any other comorbidities that would exclude her from the study. Therefore, option A (eligible) is the correct answer.","PROBA":0.9827818401},{"ID":"11768_17_NCT02793232","TOPIC_YEAR":2022,"RESPONSE":"$}}%\n\nB: excluded","PROBA":0.8183459947},{"ID":"14125_30_NCT02789163","TOPIC_YEAR":2021,"RESPONSE":"$}}%\n\nBased on the information provided, the patient is excluded from the clinical trial because of the exclusion criterion \"breast abnormality greater than one quadrant.\" The patient has a history of Hashimoto's thyroiditis, which is not relevant to the clinical trial. Therefore, the answer is (B) excluded.","PROBA":0.9970289092},{"ID":"17322_36_NCT03802734","TOPIC_YEAR":2021,"RESPONSE":"# A: eligible","PROBA":0.978709586},{"ID":"5533_12_NCT04382612","TOPIC_YEAR":2021,"RESPONSE":"$}}%\n\nBased on the patient's note and the inclusion and exclusion criteria of the clinical trial, the patient is eligible for the clinical trial. The patient has severe degenerative mitral regurgitation due to posterior leaflet prolapse, which aligns with the inclusion criteria of the clinical trial. Additionally, the patient does not have any of the exclusion criteria, such as active endocarditis, severe mitral annular and\/or leaflet calcification, or previous mitral valve replacement surgery. Therefore, the patient is eligible for the clinical trial. The correct answer is A: eligible.","PROBA":0.9924423519},{"ID":"10050_15_NCT00830583","TOPIC_YEAR":2022,"RESPONSE":"$}}%\n\nB: excluded","PROBA":0.9787034616},{"ID":"5530_12_NCT04343313","TOPIC_YEAR":2021,"RESPONSE":"$}}%\n\nB: excluded. The patient is excluded from the clinical trial because of the following exclusion criteria:\n\n* Prior mitral valve surgery or endovascular procedure (#11)\n* Known hypersensitivity or contraindication to study or procedure medications\/contrast which cannot be adequately managed medically (#27)\n* Currently pregnant, nursing, or planning to be pregnant (#28)","PROBA":0.994386073},{"ID":"10317_15_NCT03439670","TOPIC_YEAR":2022,"RESPONSE":"# A: eligible","PROBA":0.9943175092},{"ID":"30427_65_NCT00283218","TOPIC_YEAR":2021,"RESPONSE":"$}}%E2%80%8B%20B%3A%20excluded%20-%20the%20patient%20has%20cardiomyopathy%2C%20which%20is%20an%20exclusion%20criterion%20for%20the%20clinical%20trial.%20No%20other%20exclusion%20criteria%20are%20met.%20Therefore%2C%20the%20patient%20is%20excluded%20from%20participating%20in%20the%20clinical%20trial.","PROBA":0.9964573661},{"ID":"25356_36_NCT02733549","TOPIC_YEAR":2022,"RESPONSE":"$}}%A%>","PROBA":0.9463877082},{"ID":"21413_30_NCT04381624","TOPIC_YEAR":2022,"RESPONSE":"$}}%\n\nB: excluded","PROBA":0.9926965907},{"ID":"12714_27_NCT03241823","TOPIC_YEAR":2021,"RESPONSE":"$}}%\n\nB","PROBA":0.99273175},{"ID":"6561_15_NCT00068575","TOPIC_YEAR":2021,"RESPONSE":"$}}%A%]  A: eligible","PROBA":0.9557102485},{"ID":"33403_71_NCT00297154","TOPIC_YEAR":2021,"RESPONSE":"# A: eligible","PROBA":0.9956169277},{"ID":"21305_30_NCT03736109","TOPIC_YEAR":2022,"RESPONSE":"$}}%\n\nBased on the patient note, the patient is a 47-year-old woman with a history of osteoarthritis, which is a significant factor for the clinical trial. However, the patient is excluded from the trial because she has a tender swelling in the popliteal fossa and calf, which is one of the exclusion criteria. Therefore, the answer is B: excluded.","PROBA":0.9907779863}]
